Headquartered in Basel, Switzerland, Roche is a leading, research-driven healthcare company with businesses in Pharmaceuticals and Diagnostics. As the world’s largest biotech company, Roche develops clinically differentiated medicines for oncology, virology, inflammatory and metabolic diseases, and disorders of the central nervous system. Roche, a pioneer in diabetes management, is also the world’s foremost provider of in vitro diagnostics and tissue-based cancer tests. The strategic goal of Roche Personalized Healthcare comprises drugs and diagnostics that significantly improve patients’ health, quality of life and chances of survival.
This concept is based on new molecular insights as well as molecular diagnostic tests that allow more precise matching of therapy and better disease control. Therapies are tailored to groups of patients who share similarities in their clinical picture. This is the only way to specifically improve the effectiveness of medicines and maintain quality of life.
Through Roche Deutschland Holding GmbH, headquartered in Grenzach-Wyhlen, the company is represented in Germany at its sites in Mannheim, Penzberg, Grenzach-Wyhlen, Waiblingen/Remseck and Berlin with more than 13,000 employees.